Widely used:Recently Viewed
Clear All
$4 Mln
--
0.42
--
0
-130.56 %
--
0 %
6.21
-1007232
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| -99.81 | -40.80 | -95.47 | -99.61 | -95.06 | -81.97 | -- |
|
BSE Sensex*
| 12.20 | -0.16 | 1.32 | 22.81 | 11.05 | 16.56 | 11.80 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
ENDRA Life Sciences (NDRA)
| -47.91 | -70.59 | -7.73 | -55.36 | 12.00 | -68.94 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
$3.74 Mln
$0.43 Mln
$0.00 Mln
$6.40 Mln
$0.28 Mln
Moderate
$0.19 - 138.50
18,139,800
NASDAQ: NDRA
Ann Arbor, MI
https://endrainc.com
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in... tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Read more
The total asset value of ENDRA Life Sciences Inc (NDRA) stood at $ 12 Mln as on 30-Jun-24
The share price of ENDRA Life Sciences Inc (NDRA) is $0.21 (NASDAQ) as of 04-Oct-2024 16:26 EDT. ENDRA Life Sciences Inc (NDRA) has given a return of -95.06% in the last 3 years.
ENDRA Life Sciences Inc (NDRA) has a market capitalisation of $ 4 Mln as on 04-Oct-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of ENDRA Life Sciences Inc (NDRA) is 0.42 times as on 04-Oct-2024, a 87% discount to its peers’ median range of 3.12 times.
Since, TTM earnings of ENDRA Life Sciences Inc (NDRA) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the ENDRA Life Sciences Inc (NDRA) and enter the required number of quantities and click on buy to purchase the shares of ENDRA Life Sciences Inc (NDRA).
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
The CEO & director of Mr. Francois Michelon. is ENDRA Life Sciences Inc (NDRA), and CFO & Sr. VP is Mr. Francois Michelon.
There is no promoter pledging in ENDRA Life Sciences Inc (NDRA).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,034
|
|
|
1,002
|
|
|
998
|
|
|
875
|
| ENDRA Life Sciences Inc. (NDRA) | Ratios |
|---|---|
|
Return on equity(%)
|
-130.56
|
|
Operating margin(%)
|
-2240.44
|
|
Net Margin(%)
|
-2232.74
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of ENDRA Life Sciences Inc (NDRA) was $0 Mln.
$0.00
